Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens
{{output}}
Globally, it is predicted that by 2050, 10 million people will die annually because of infections with drug-resistant bacteria. Since antibacterial agents with novel mechanisms of action have not been developed in the past 30 years, there has been a surge of i... ...
